COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2022	Mar. 31, 2021
Weighted Average Discount Rate Operating Lease	9.10%
Current portion of the operating lease obligation				$ 200,000
Increase In Right Of Use Asset And Liability	$ 1,100,000
Operating Lease Liabilities	2,000,000.0
Research And Development Expenses	35,600,000
Operating Lease Right Of Use Assets	1,800,000		$ 1,900,000
Current Balance	200,000
Net Of Discount	11,800,000
Operating Lease Expense	91,000	$ 91,000
Operating Lease Payment	$ 85,000	66,000
Weighted Average Time To Maturity	5 years 29 days
Landlord [Member]
Interest Rate	8.45%
Financing arrangement deposit base rent amount	$ 2,400,000
Financing arrangement deposit base rent percentage description	The repayment includes a base rent which escalates at 3% each year plus interest that accrues at 13.75% per year.
Financing Arrangement	$ 11,100,000
Payments Made By Landlord	$ 2,400,000
Transaction One [Member]
Weighted average maturity date of operating leases	7 years 7 months 6 days
Weighted Average Discount Rate	8.45%
Net Book Value Of The Finance Lease Right Of Use Asset	$ 10,500,000		$ 1,090,000
Balance Of The Finance Lease Liability	12,900,000
Cash Paid Related To Finance Leases	600,000
Cash Paid Related To Finance Leases Interest	300,000
Ergomed [Member]
Research And Development Expenses	10,000	$ 200,000
Clinical Service Trial	$ 12,000,000